Intraocular Pressure and Anterior Segment Morphometry Changes after Uneventful Phacoemulsification in Type 2 Diabetic and Nondiabetic Patients
Table 3
Subgroup analysis of DM and non-DM groups according preoperative IOP subgroups.
Pre-op. IOP
Eyes (n, %)
Age (y)
IOP pre-op. (mmHg)
IOP Δ 6 mo (mmHg)
ACD pre-op (mm)
ACD Δ 6 mo (mm)
ACV pre-op (mm3)
ACV Δ 6 mo (mm3)
ACA pre-op (°)
ACA Δ 6 mo (°)
DM group (n = 45)
21–25
9 (20%)
73 ± 7
22.0 ± 1.3
−4.8 ± 2.7
2.5 ± 0.4
+1.5 ± 0.2
129 ± 41
+59 ± 13
30 ± 5
+15 ± 7
19-20
11 (24%)
72 ± 4
19.4 ± 0.5
−3.3 ± 2.3
2.5 ± 0.3
+1.2 ± 0.4
118 ± 22
+46 ± 21
29 ± 5
+13 ± 5
17-18
9 (20%)
70 ± 7
17.7 ± 0.5
−4.1 ± 2.3
2.5 ± 0.3
+1.4 ± 0.2
119 ± 33
+55 ± 21
29 ± 4
+15 ± 5
15-16
7 (16%)
72 ± 4
15.6 ± 0.5
−1.7 ± 2.1
2.5 ± 0.4
+1.5 ± 0.3
122 ± 35
+59 ± 27
27 ± 5
+16 ± 3
10–14
9 (20%)
77 ± 4
13.3 ± 0.7
−0.4 ± 3.2
2.8 ± 0.3
+1.3 ± 0.2
146 ± 35
+46 ± 29
35 ± 7
+12 ± 5
0.6761
0.1402
<0.001
0.028
0.3202
0.1092
0.4012
0.6942
0.0882
0.4162
Non-DM group (n = 44)
21–25
4 (9%)
76 ± 12
22.5 ± 1.3
−7.0 ± 1.4
2.6 ± 0.4
+1.3 ± 0.2
116 ± 23
+50 ± 27
29 ± 4
+9 ± 5
19-20
8 (18%)
70 ± 5
19.5 ± 0.5
−3.4 ± 2.1
2.7 ± 0.5
+1.3 ± 0.3
145 ± 41
+39 ± 31
35 ± 6
+11 ± 8
17-18
10 (23%)
70 ± 6
17.6 ± 0.5
−2.7 ± 1.0
2.7 ± 0.3
+1.3 ± 0.3
139 ± 24
+49 ± 16
35 ± 5
+12 ± 5
15-16
15 (34%)
70 ± 6
15.5 ± 0.5
−1.8 ± 3.1
2.6 ± 0.4
+1.4 ± 0.3
135 ± 35
+53 ± 22
31 ± 6
+15 ± 5
10–14
7 (16%)
71 ± 4
12.7 ± 1.5
+0.1 ± 1.5
2.8 ± 0.5
+1.3 ± 0.4
152 ± 48
+52 ± 29
34 ± 6
+14 ± 7
0.7591
0.9282
<0.001
0.001
0.7972
0.7632
0.4692
0.7152
0.1432
0.5162
Data were derived from Fisher’s exact test1 and Kruskal–Wallis test2. Continuous variables are reported as mean ± standard deviation. , statistical significance. ACA, anterior chamber angle; ACD, anterior chamber depth; ACV, anterior chamber volume; IOP, intraocular pressure; mm, millimeters; mo, months; Δ, variation.
